Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.465
-0.035 (-1.00%)
Dec 3, 2024, 1:54 PM EST - Market open
Atea Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 98.46 | 143.82 | 188.46 | 764.38 | 850.12 | 21.66 | Upgrade
|
| Short-Term Investments | 384.35 | 434.28 | 458.25 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 482.81 | 578.11 | 646.71 | 764.38 | 850.12 | 21.66 | Upgrade
|
| Cash Growth | -18.87% | -10.61% | -15.39% | -10.09% | 3824.64% | -37.20% | Upgrade
|
| Accounts Receivable | - | - | - | - | 5.82 | - | Upgrade
|
| Other Receivables | - | 5.9 | - | - | - | - | Upgrade
|
| Receivables | - | 5.9 | - | - | 5.82 | - | Upgrade
|
| Prepaid Expenses | 4.09 | 6.45 | 14.21 | 8.03 | 7.55 | 0.25 | Upgrade
|
| Total Current Assets | 486.91 | 590.46 | 660.92 | 772.4 | 863.48 | 21.91 | Upgrade
|
| Property, Plant & Equipment | 2.37 | 3.12 | 4.09 | 0.18 | 0.05 | 0.04 | Upgrade
|
| Other Long-Term Assets | 1.68 | 1.4 | 1.69 | 0.31 | 0.11 | 0.12 | Upgrade
|
| Total Assets | 490.96 | 594.97 | 666.71 | 772.89 | 863.63 | 22.07 | Upgrade
|
| Accounts Payable | 5.79 | 4.25 | 2.55 | 4.53 | 0.06 | 0.55 | Upgrade
|
| Accrued Expenses | 18.62 | 27.36 | 15.11 | 24.58 | 14.37 | 1.69 | Upgrade
|
| Current Portion of Leases | 0.79 | 0.76 | 0.72 | 0.2 | - | - | Upgrade
|
| Current Income Taxes Payable | - | - | 0.1 | 2.57 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 301.37 | - | Upgrade
|
| Other Current Liabilities | - | - | - | 25 | - | 0.2 | Upgrade
|
| Total Current Liabilities | 25.19 | 32.38 | 18.48 | 56.88 | 315.8 | 2.44 | Upgrade
|
| Long-Term Leases | 1.05 | 1.64 | 2.4 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 6.2 | 5.76 | 5.26 | 5.93 | 0.04 | 0.1 | Upgrade
|
| Total Liabilities | 32.44 | 39.78 | 26.14 | 62.82 | 315.83 | 2.53 | Upgrade
|
| Common Stock | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 788.47 | 750.74 | 701.05 | 653.96 | 612.88 | 4.63 | Upgrade
|
| Retained Earnings | -330.68 | -195.84 | -59.88 | 56.03 | -65.16 | -54.21 | Upgrade
|
| Comprehensive Income & Other | 0.64 | 0.21 | -0.68 | - | - | - | Upgrade
|
| Total Common Equity | 458.52 | 555.19 | 640.57 | 710.08 | 547.8 | -49.57 | Upgrade
|
| Shareholders' Equity | 458.52 | 555.19 | 640.57 | 710.08 | 547.8 | 19.54 | Upgrade
|
| Total Liabilities & Equity | 490.96 | 594.97 | 666.71 | 772.89 | 863.63 | 22.07 | Upgrade
|
| Total Debt | 1.84 | 2.4 | 3.12 | 0.2 | - | - | Upgrade
|
| Net Cash (Debt) | 480.98 | 575.7 | 643.59 | 764.18 | 850.12 | 21.66 | Upgrade
|
| Net Cash Growth | -18.83% | -10.55% | -15.78% | -10.11% | 3824.64% | -37.20% | Upgrade
|
| Net Cash Per Share | 5.73 | 6.90 | 7.73 | 8.66 | 39.37 | 2.15 | Upgrade
|
| Filing Date Shares Outstanding | 84.46 | 84.16 | 83.34 | 83.23 | 82.74 | 10.31 | Upgrade
|
| Total Common Shares Outstanding | 84.46 | 83.44 | 83.29 | 83.1 | 82.44 | 10.09 | Upgrade
|
| Working Capital | 461.72 | 558.08 | 642.44 | 715.52 | 547.68 | 19.48 | Upgrade
|
| Book Value Per Share | 5.43 | 6.65 | 7.69 | 8.54 | 6.65 | -4.91 | Upgrade
|
| Tangible Book Value | 458.52 | 555.19 | 640.57 | 710.08 | 547.8 | -49.57 | Upgrade
|
| Tangible Book Value Per Share | 5.43 | 6.65 | 7.69 | 8.54 | 6.65 | -4.91 | Upgrade
|
| Machinery | - | 0.5 | 0.5 | 0.06 | 0.06 | 0.03 | Upgrade
|
| Leasehold Improvements | - | 1.48 | 1.48 | 0.13 | 0.13 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.